Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.65
+0.04 (0.80%)
At close: Jul 18, 2025, 4:00 PM
5.64
0.00 (-0.09%)
After-hours: Jul 18, 2025, 5:23 PM EDT
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $492.59 million as of July 18, 2025. Its market cap has increased by 13.33% in one year.
Market Cap
492.59M
Enterprise Value
159.56M
1-Year Change
13.33%
Ranking
Category
Stock Price
$5.65
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $492.59M, an increase of 243.00%. That is a compound annual growth rate of 31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 492.59M | 4.68% |
| Dec 31, 2024 | 470.56M | 17.33% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 692.79B |
| Johnson & Johnson | 393.87B |
| AbbVie | 334.31B |
| Novo Nordisk | 287.38B |
| UnitedHealth Group | 256.40B |
| Novartis AG | 223.49B |
| Abbott Laboratories | 215.17B |
| AstraZeneca | 214.61B |